Boureka Eirini, Ralli Elpiniki-Elpida, Arvanitaki Alexandra, Lefkou Eleftheria, Fragakis Nikolaos, Giannakoulas George, Mamopoulos Apostolos, Dagklis Themistoklis, Tsakiridis Ioannis
Resident, Third Department of Obstetrics and Gynaecology.
Clinical Reader, Second Cardiology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki.
Obstet Gynecol Surv. 2025 Jun;80(6):376-390. doi: 10.1097/OGX.0000000000001407.
Venous thromboembolism (VTE) manifesting either as deep vein thrombosis or pulmonary embolism presents as the leading cause of maternal morbidity and mortality, worldwide.
The aim of this study was to review and compare the most recently published international guidelines on the diagnosis and management of acute VTE in pregnancy and the puerperium.
A comparative review of guidelines by the American College of Obstetricians and Gynecologists, the Royal College of Obstetricians and Gynecologists, the Royal Australian and New Zealand College of Obstetricians and Gynecologists, the Society of Obstetricians and Gynecologists of Canada, the American College of Chest Physicians, the European Society of Cardiology, and the American Society of Hematology on VTE was conducted.
There is a consensus among the reviewed guidelines regarding the appropriate algorithm for diagnosis of VTE in the obstetric population, the appropriate anticoagulants suitable for the pregnancy and puerperium, even in cases of contraindications for heparin, and indications for extreme management measures, such as thrombolysis. On the other hand, few discrepancies were detected on the dosage of anticoagulants, indications of anticoagulation monitoring, appropriate management of anticoagulants related to neuraxial anesthesia, and indications for thrombophilia testing following a VTE event. Notably, only the European Society of Cardiology recommends the use of models assessing the clinical likelihood of pulmonary embolism, suggests a risk stratification algorithm to guide acute management, and proposes management strategies for the prevention of hemorrhagic events during labor.
VTE is a significant contributor of maternal morbidity and mortality, especially if managed in a suboptimal way. Hence, the development of consistent evidence-based protocols and algorithms is crucial to safely guide pregnant women and their physicians toward reducing improving fetal and maternal outcomes.
静脉血栓栓塞症(VTE)表现为深静脉血栓形成或肺栓塞,是全球孕产妇发病和死亡的主要原因。
本研究的目的是回顾和比较最近发表的关于妊娠和产褥期急性VTE诊断和管理的国际指南。
对美国妇产科医师学会、皇家妇产科医师学院、澳大利亚和新西兰皇家妇产科医师学院、加拿大妇产科医师学会、美国胸科医师学会、欧洲心脏病学会和美国血液学会关于VTE的指南进行了比较回顾。
在审查的指南中,对于产科人群VTE的适当诊断算法、适合妊娠和产褥期的适当抗凝剂(即使在肝素禁忌的情况下)以及极端管理措施(如溶栓)的指征达成了共识。另一方面,在抗凝剂剂量、抗凝监测指征、与椎管内麻醉相关的抗凝剂的适当管理以及VTE事件后血栓形成倾向检测的指征方面发现了一些差异。值得注意的是,只有欧洲心脏病学会推荐使用评估肺栓塞临床可能性的模型,提出了指导急性管理的风险分层算法,并提出了预防分娩期间出血事件的管理策略。
VTE是孕产妇发病和死亡的重要原因,尤其是管理不当时。因此,制定一致的循证方案和算法对于安全指导孕妇及其医生改善胎儿和孕产妇结局至关重要。